SureTrader SureTrader
Home > Boards > US Listed > Biotechs >

Anthera Pharmaceuticals, Inc. (ANTH)

ANTH RSS Feed
Add ANTH Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board:
Last Post: 8/19/2016 4:48:17 PM - Followers: 51 - Board type: Free - Posts Today: 0

http://www.anthera.com/

http://finance.yahoo.com/q?s=ANTH


Anthera Pharmaceuticals Inc. Nasdaq traded


   Anthera Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products to treat serious diseases associated with inflammation,

including cardiovascular and autoimmune diseases. We currently have a Phase 2 clinical program, blisibimod.It was just recently approved by FDA to move into

PHASE 3

 

   Blisibimod targets elevated levels of B-cell activating factor (BAFF), which has been associated with a variety of B-cell mediated autoimmune diseases, including systemic lupus erythematosus (SLE), rheumatoid arthritis, multiple sclerosis, Sjögren's Syndrome, Graves' Disease and others.


  It has taken the lupus research community over 50 years to produce a new therapy. Although it is now a year old, Benlysta (belimumab),

now marketed by GlaxoSmithKline and Human Genome Sciences, is the first human monoclonal antibody for the treatment

of lupus.




  Benlysta had a slow take-off grossing $59.2 million in sales in the last three quarters of 2011, but it was approved in numerous

countries by year's end.
Estimated sales for Benlysta in 2012 are said to be about $230 million, with first annual profits likely by 2015.


  The surprisingly slow uptake of Benlysta allows for blisibimod to develop into a promising drug as

it currently has more desirable features than that of Benlysta.


Blisibimod has a dosing regimen of one injection weekly, compared to that of Benlysta which requires a

series of dosing before the maintenance dose begins. Also, Benlysta has limitations on usage pertaining to

specific patient populations and has not been studied in combination with other biologics.

These attributes of blisibimod including a different mechanism of action, will set it apart from

Benlysta, Global Data concludes.

 

 

http://static.cdn-seekingalpha.com/uploads/2012/7/16/1342291-13424315435921793-Jorge-Aura.png

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ANTH
Current Price
Volume:
Bid Ask Day's Range
SureTrader
ANTH News: Statement of Changes in Beneficial Ownership (4) 09/22/2016 07:30:16 PM
ANTH News: Statement of Ownership (sc 13g) 09/16/2016 05:15:08 PM
ANTH News: Current Report Filing (8-k) 09/15/2016 04:20:24 PM
ANTH News: Current Report Filing (8-k) 09/12/2016 04:23:08 PM
ANTH News: Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) 09/08/2016 04:28:07 PM
PostSubject
#1951   ANTH bearish 3.13 stocktrademan 08/19/16 04:48:17 PM
#1950   A burst on the opening to $4. Backed off Jacque_Strap 07/11/16 10:01:04 AM
#1949   Agreed. Let's see if if closes near $5 by the Jacque_Strap 07/10/16 06:41:13 PM
#1948   Looks like we might get a good run jimmy667 07/10/16 11:07:08 AM
#1947   Impressive price action while most hit the dirt jimmy667 06/26/16 03:31:18 PM
#1946   Anthera Craig Thompson, President and COO of $ANTH, to Paulieme 06/21/16 03:07:44 PM
#1945   ANTH bearish 3.02 stocktrademan 06/17/16 01:02:01 PM
#1944   5/9 earnings and updates on their pipeline. Would love Jacque_Strap 05/01/16 07:40:00 PM
#1943   Up over 11% today on above avg volume. Shareholders Jacque_Strap 04/21/16 09:28:06 PM
#1942   $ANTH recent news/filings stocktrademan 03/17/16 11:46:14 AM
#1941   Anthera Pharmaceuticals Inc (NASDAQ:ANTH) Given Consensus Rating of Paulieme 03/04/16 12:31:30 AM
#1940   Rhenman & Partners Asset Management Has $1,160,000 Position Paulieme 02/25/16 06:06:32 PM
#1939   Anthera Pharmaceuticals Inc (ANTH) PT Lowered to $11.00 Paulieme 02/21/16 06:23:13 PM
#1938   Anthera Pharmaceuticals, Inc. (NASDAQ:ANTH): Zacks Growth Score Paulieme 02/15/16 12:30:32 PM
#1937   Zacks: Anthera Pharmaceuticals Inc (NASDAQ:ANTH) Given $13.33 Average Paulieme 02/09/16 02:06:49 PM
#1936   Anthera Pharmaceuticals Inc (ANTH) Sets New 1-Year Low Paulieme 02/08/16 10:55:51 PM
#1935   California State Teachers Retirement System Increases Stake in Paulieme 02/07/16 11:20:53 PM
#1934   Zacks: Anthera Pharmaceuticals Inc (NASDAQ:ANTH) Receives Average Recommendation Paulieme 02/04/16 11:01:22 PM
#1933   Anthera Pharmaceuticals: Buy Low Opportunity On Potential Drug Approval Paulieme 02/04/16 10:56:38 PM
#1932   niceeeeeeeeeeee Tdash 01/20/16 02:24:48 PM
#1931   Something may be brewing, although volume low docoroc2 12/17/15 09:57:34 PM
#1930   $ANTH $13-$15 price targets Stock General 09/28/15 10:56:02 AM
#1929   That's great. Thanks for that tip. I wish tpizzazz24 07/30/15 06:44:17 AM
#1928   What? Dude I shorted and covered on this investorsito 07/30/15 06:38:20 AM
#1927   Any more predictions? tpizzazz24 07/30/15 03:10:43 AM
#1926   $6 eow investorsito 06/29/15 09:36:43 AM
#1925   Power dump hour. Glta. investorsito 06/26/15 02:59:36 PM
#1924   Last chance to take profits before the Friday investorsito 06/26/15 12:38:18 PM
#1923   Descend to $6 underway investorsito 06/26/15 10:44:16 AM
#1922   Here comes the drop below 8. sellers are investorsito 06/26/15 10:29:17 AM
#1921   The Friday afternoon dump will be swift. Congrats investorsito 06/25/15 03:08:28 PM
#1920   No products in the market. No guarantee Blisibimod investorsito 06/25/15 11:54:06 AM
#1919   BIG SHORT,63,828 SHARES $8.40 RED IN BID, 9:42 HS lecorb 06/25/15 10:07:42 AM
#1918   ANTH: Break point in the PPO, Very negative! lecorb 06/24/15 09:04:47 PM
#1917   Does anyone know what time frame the next Want2BMillionaire 06/15/15 10:49:48 AM
#1916   Darn! I sold my position a few weeks mantisforce 06/06/15 11:05:34 AM
#1915   **ANTH** Anthera Pharmaceuticals Announces Additional Data on Patient-Reported aetosellinas 06/05/15 05:57:21 AM
#1914   $ANTH recent news/filings stocktrademan 05/29/15 02:40:31 PM
#1913   Buy order in 5.20. Might get filled cakesgood 05/29/15 11:48:36 AM
#1912   Anthera Pharmaceuticals Reports 2015 First Quarter and Operational Update PennyMoocher69 05/12/15 07:52:46 AM
#1911   Anthera Pharmaceuticals Receives “Buy” Rating from Zacks (ANTH) PennyMoocher69 05/02/15 08:27:35 AM
#1910   Yes she did. Like I said it has PennyMoocher69 05/02/15 07:23:05 AM
#1909   Yes, maybe. I will probably reconsider. It looks Want2BMillionaire 05/01/15 07:14:23 PM
#1908   I bought this for just over a dollar PennyMoocher69 04/30/15 07:38:49 PM
#1907   Hello PennyMoocher. Thank you for the info. I Want2BMillionaire 04/30/15 04:23:24 PM
#1906   Hello PennyMoocher. Thank you for the info. I Want2BMillionaire 04/30/15 04:22:57 PM
#1905   http://www.biopharmcatalyst.com/clinical-database/ Anthera Pharmaceuticals PennyMoocher69 04/29/15 07:31:03 PM
#1904   GM everyone! ANTH has 2 PH3 studies going, Want2BMillionaire 04/29/15 10:27:16 AM
#1903   Good thing you aren't holding now. Tomorrow they'll KingDMC 03/17/15 07:41:05 PM
#1902   I didn't have the stones to get involved AwolfmanH 03/17/15 07:20:03 PM
PostSubject